OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9807	Companies
196726	Keywords
127735	Articles
104592	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 08/04/2025 at 18:00, 6 months ago

Oxurion kondigt aan dat het een verbeterd indicatief financieringsaanbod van EUR 30 miljoen heeft gekregen om de diversificatie van een deel van zijn kasmiddelen naar digitale activa te starten
Oxurion NV ontvangt een verbeterd financieringsaanbod van €30 miljoen van Atlas Special Opportunities voor investering in digitale activa. Financiering in tien schijven via converteerbare obligaties om kasmiddelen te diversifiëren

Atlas Special Opportunities Oxurion NV Converteerbare Obligaties Financieringsaanbod Digitale Activa
PRESS RELEASE

published on 08/04/2025 at 18:00, 6 months ago

Oxurion obtient une offre de financement revue à la hausse à 30 M EUR pour lancer la diversification de sa trésorerie en actifs numériques
Oxurion NV reçoit une offre de financement de 30 millions d'euros d'Atlas Special Opportunities pour investir dans Bitcoin et Ethereum. Objectif de diversification de la trésorerie

Financement Bitcoin Ethereum Oxurion NV 30 Millions D'euros
BRIEF

published on 08/04/2025 at 08:35, 6 months 1 day ago

Oxurion conclut l'acquisition de 72% d'Axiodis CRO

Acquisition Croissance Externe Données Cliniques Oxurion Axiodis CRO
BRIEF

published on 08/04/2025 at 08:35, 6 months 1 day ago

Oxurion completes acquisition of 72% of Axiodis CRO

Acquisition External Growth Clinical Data Oxurion Axiodis CRO
PRESS RELEASE

published on 08/04/2025 at 08:30, 6 months 1 day ago

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe

Acquisition Europe Intégration Clinical Data Oxurion
PRESS RELEASE

published on 08/04/2025 at 08:30, 6 months 1 day ago

Oxurion finalise l'acquisition d'Axiodis CRO et accélère la structuration de son pôle européen dédié à la donnée clinique
Oxurion finalise l'acquisition de 72?% du capital d'Axiodis CRO, marquant la première étape vers un pôle intégré de donnée clinique en France et en Europe

Acquisition Stratégie De Croissance Biopharmaceutique Donnée Clinique Oxurion
PRESS RELEASE

published on 08/04/2025 at 08:30, 6 months 1 day ago

Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten

Übernahme Partnerschaften Oxurion Axiodis CRO Klinische Daten
BRIEF

published on 07/30/2025 at 18:05, 6 months 5 days ago

Oxurion Réceptionne une Notification de Transparence Modifiée

Actions Transparence Atlas Special Opportunities Oxurion Bio-pharmaceutique
BRIEF

published on 07/30/2025 at 18:05, 6 months 5 days ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 6 months 5 days ago

Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding threshold

Transparency Notification Shareholding Belgium Oxurion NV Atlas Special Opportunities II LLC

Accesswire

Published on 02/05/2026 at 09:05, 2 hours 29 minutes ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 9 hours 59 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 11 hours 34 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 9 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 17 hours 34 minutes ago

Lithium South AGSM Update

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 11:16, 18 minutes ago

FUCHS strengthens its presence in Türkiye with the complete takeover of the joint venture OPET FUCHS
Published on 02/05/2026 at 11:00, 33 minutes ago

CHANGES TO THE BOARD OF DIRECTORS
Published on 02/05/2026 at 10:48, 45 minutes ago

EQS-Adhoc: Evonik Industries AG: Executive Board adjusts dividend policy
Published on 02/05/2026 at 10:05, 1 hour 28 minutes ago

VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
Published on 02/05/2026 at 10:05, 1 hour 28 minutes ago

Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese

Les Echos

Published on 02/05/2026 at 11:30, 4 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 4 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 17 hours 29 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 17 hours 29 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 17 hours 49 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE